Alcohol and Maternal Uterine Vascular Adaptations in Pregnancy
妊娠期酒精与母体子宫血管适应
基本信息
- 批准号:9053392
- 负责人:
- 金额:$ 32.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-15 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAlcohol abuseAlcohol consumptionAlcoholsArteriesAttentionBehavioralBirth WeightBlood CirculationBlood VesselsBrainChildChronicComplexDataDevelopmentEndotheliumEpoprostenolFetal Alcohol ExposureFetal Alcohol Spectrum DisorderFetal Alcohol SyndromeFetal GrowthFunctional disorderGoalsGrowthHealthHistologyHumanImage AnalysisImmunoblottingImpairmentIndividualMeasuresMethodsModelingMyographyNOS3 geneNational Institute on Alcohol Abuse and AlcoholismNeonatalNeurodevelopmental DeficitNitric OxideNitric Oxide SynthaseOutcomePathway interactionsPhosphorylation SitePregnancyPrevalencePrevention strategyProductionProstaglandins IRattusRegulationRelaxationResearchReverse Transcriptase Polymerase Chain ReactionSalineSchoolsSpectrophotometrySpeedStrategic PlanningSystemTestingTimeUnited StatesVascular DiseasesVasodilationVasodilator Agentsalcohol effectalcohol exposurealcohol researchbinge drinkingbody systemcostdisabilityeffective interventionfeedingfetalfluorescence imagingfrontierin vivoin vivo Modelindexinginnovationnovelnutritionpregnantpreventprogramsreproductiveresearch study
项目摘要
DESCRIPTION (provided by applicant): Alcohol & Maternal Uterine Vascular Adaptations in Pregnancy Maternal alcohol abuse during pregnancy can result in Fetal Alcohol Spectrum Disorders (FASD), a lifelong disability characterized by a range of growth and developmental deficits. Current estimates of FASD prevalence is about 2-5% among young school children in the United States. Efforts to successfully prevent or ameliorate the teratogenic effects of ethanol
have been impeded, at least in part, by a limited understanding of alcohol's complex mechanisms of action involving multiple organ systems. A normal pregnancy is associated with major uterine circulatory adaptations that directly relates to fetal growth, neonatal birth weights
and survival. A cardinal feature of fetal alcohol syndrome is growth restriction, but traditionally
alcohol studies have focused on brain/behavioral deficits, and little attention has been paid to critical gestational uterine vascular adaptations. We herein show novel preliminary data that alcohol impairs the exquisite regulation of gestational uterine circulatory adaptations in rat bing alcohol model. We herein hypothesize that chronic binge alcohol exposure during pregnancy impairs maternal uterine artery vascular adaptations via endothelial nitric oxide (NO) system dysregulation. Aim#1 will test the hypothesis that binge alcohol exposure in pregnancy leads to impaired endothelium-dependent maternal uterine artery relaxation. Following binge paradigm, we will assess growth indices, and utilize wire myography to study agonist-induced uterine artery relaxation in endothelium-intact/denuded vessels from saline control, pair-fed nutrition control, and alcohol rats. Aim#2 will test if binge alcohol impairs uterine artery relaxation via endothelium-derived NO relative to prostacyclin/endothelium-derived hyperpolarizing factor, decreases uterine artery NO production, endothelial NO synthase (eNOS) expression, and impairs eNOS multi-site phosphorylation. Aim#3 will test if binge alcohol decreases uterine artery NO, decreases excitatory Pser1177eNOS levels, and increases inhibitory Pthr495eNOS levels via ERK/AMPK pathway, and alcohol effects on endothelial [Ca+2]i transients. In Aims#2 and #3, we will assess uterine artery relaxation after blocking major vasodilatory pathways and conduct mechanistic studies with/without eNOS activity/multi-site phosphorylation-regulating pathway antagonists via RT-PCR, immunoblotting, histology, fluorescent imaging and spectrophotometry. Simultaneous [Ca2+]i-NO fluorescent imaging will be performed utilizing high-speed excitation/emission wavelength switching system. Our proposal explores a new frontier of gestational alcohol research by developing the first mechanistic framework for binge alcohol-induced uterine artery adaptations and identifying alcohol targets in an in vivo model. In alignment with NIAAA FY14 Strategic Plan, our proposal utilizes powerful methods and presents a new maternal-inclusive paradigm to the FAS field and predicts that a more effective intervention will require innovative pharmacologic targeting of maternal systems, especially the critical uterine circulation, in order to predict and propose a therapy that will have a real promie as a preventive strategy.
描述(由申请人提供):怀孕期间的酒精与孕产妇子宫血管适应孕妇在怀孕期间酗酒可能会导致胎儿酒精谱系障碍(FASD),这是一种终身残疾,其特征是一系列生长和发育缺陷。目前估计FASD患病率约为2-5%的年轻学生在美国。成功预防或改善乙醇致畸作用的努力
由于对酒精涉及多个器官系统的复杂作用机制的了解有限,至少部分地受到阻碍。正常妊娠与子宫循环系统的主要适应性相关,这些适应性直接关系到胎儿生长、新生儿出生体重
和生存胎儿酒精综合征的一个主要特征是生长受限,但传统上
酒精研究集中在大脑/行为缺陷上,而很少关注关键的妊娠子宫血管适应。在此,我们展示了新的初步数据,即酒精损害大鼠酒精模型妊娠子宫循环适应的精细调节。我们在此假设,慢性酗酒暴露在怀孕期间损害母体子宫动脉血管适应通过内皮一氧化氮(NO)系统失调。目标1将检验妊娠期酗酒暴露导致内皮依赖性母体子宫动脉舒张受损的假设。根据狂欢模式,我们将评估生长指数,并利用钢丝肌造影术研究激动剂诱导的子宫动脉舒张的内皮完整/裸露的血管生理盐水对照,成对喂养的营养控制,和酒精大鼠。目标#2将测试酗酒是否通过相对于前列环素/内皮衍生超极化因子的内皮衍生NO损害子宫动脉舒张,降低子宫动脉NO产生、内皮NO合酶(eNOS)表达,并损害eNOS多位点磷酸化。目的#3将测试酗酒是否通过ERK/AMPK途径降低子宫动脉NO,降低兴奋性Pser 1177 eNOS水平,并增加抑制性Pthr 495 eNOS水平,以及酒精对内皮[Ca+2]i瞬变的影响。在目标#2和#3中,我们将评估阻断主要血管舒张通路后的子宫动脉舒张,并通过RT-PCR、免疫印迹、组织学、荧光成像和分光光度法进行有/无eNOS活性/多位点磷酸化调节通路拮抗剂的机制研究。同时[Ca 2 +]i-NO荧光成像将利用高速激发/发射波长切换系统进行。我们的提案通过开发第一个酗酒诱导的子宫动脉适应机制框架和在体内模型中识别酒精靶点,探索了妊娠期酒精研究的新前沿。与NIAAA FY 14战略计划一致,我们的提案利用了强大的方法,并为FAS领域提供了一种新的母亲包容性范例,并预测更有效的干预将需要创新的药物靶向母体系统,特别是关键的子宫循环,以预测和提出一种具有真实的预防策略的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jayanth Ramadoss其他文献
Jayanth Ramadoss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jayanth Ramadoss', 18)}}的其他基金
ELECTRONIC CIGARETTE VAPING & VASCULAR SEQUELAE IN THE UTERUS DURING PREGNANCY.
电子烟
- 批准号:
10540752 - 财政年份:2021
- 资助金额:
$ 32.74万 - 项目类别:
ELECTRONIC CIGARETTE VAPING & VASCULAR SEQUELAE IN THE UTERUS DURING PREGNANCY.
电子烟
- 批准号:
10459954 - 财政年份:2021
- 资助金额:
$ 32.74万 - 项目类别:
ELECTRONIC CIGARETTE VAPING & VASCULAR SEQUELAE IN THE UTERUS DURING PREGNANCY.
电子烟
- 批准号:
10324577 - 财政年份:2021
- 资助金额:
$ 32.74万 - 项目类别:
ELECTRONIC CIGARETTE VAPING & VASCULAR SEQUELAE IN THE UTERUS DURING PREGNANCY
电子烟
- 批准号:
10116886 - 财政年份:2021
- 资助金额:
$ 32.74万 - 项目类别:
A Novel Platform for Maternal Alcohol Consumption Screening
孕产妇酒精摄入量筛查的新平台
- 批准号:
8822061 - 财政年份:2015
- 资助金额:
$ 32.74万 - 项目类别:
A Novel Mechanistic Framework for FASD Etiology.
FASD 病因学的新机制框架。
- 批准号:
10598031 - 财政年份:2015
- 资助金额:
$ 32.74万 - 项目类别:
A Novel Mechanistic Framework for FASD Etiology.
FASD 病因学的新机制框架。
- 批准号:
10377467 - 财政年份:2015
- 资助金额:
$ 32.74万 - 项目类别:
A Novel Mechanistic Framework for FASD Etiology.
FASD 病因学的新机制框架。
- 批准号:
10459965 - 财政年份:2015
- 资助金额:
$ 32.74万 - 项目类别:
A Novel Platform for Maternal Alcohol Consumption Screening
孕产妇酒精摄入量筛查的新平台
- 批准号:
9136036 - 财政年份:2015
- 资助金额:
$ 32.74万 - 项目类别:
Maternal Uterine Vascular Origins of Fetal Alcohol Spectrum Disorders
胎儿酒精谱系疾病的母体子宫血管起源
- 批准号:
8040970 - 财政年份:2010
- 资助金额:
$ 32.74万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 32.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 32.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 32.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)